drugset / Trial / NCT00115817

The Effects of Atorvastatin in Patients With Atherosclerosis

NCT00115817 ↗

Phase 3 Completed 36 enrolled Brigham and Women's Hospital
RandomizedFactorialDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effects of Atorvastatin. The investigators want to find out if atorvastatin has other helpful qualities. The investigators are interested in finding out if medicines like atorvastatin are useful even in people who do not have high levels of bad cholesterol and would like to understand other mechanisms by which this medicine helps prevent further blood vessel disease. Hypotheses: 1. Atorvastatin reduces Rho kinase activity (in leukocytes) rapidly, within days, in patients with atherosclerosis. 2. Any decrease in Rho kinase activity with statin therapy will be accompanied by improvement in familiar markers of atherosclerosis.

Timeline

Start
2005-06
Primary completion
—
Completion
2007-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 10 mg Oral
Subject Atorvastatin Small molecule 80 mg Oral

Indications